Clear cell sarcoma

Clear cell sarcoma is an aggressive tumour. The rate of survival remains modest. The early identification of metastases using PET CT allowed for more focused treatment. The local follow-up protocol must appreciate the wide variations in the time to recurrence. Targeted immunological systemic treatments may improve the outcomes in the future.

Authors

James E. Archer (ORCID: https://orcid.org/0000-0001-7329-2401)
Scott Evans
Natalie Green
Charles A. E. Baird

Institutions

Royal Orthopaedic Hospital (GB)

Publication Details

Journal: The Bone & Joint Journal
Published: 2026-02-01
DOI: https://doi.org/10.1302/0301-620x.108b2.bjj-2025-0526.r1
Primary Topic: Sarcoma Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Clear cell sarcoma

James E. Archer, Scott Evans, Natalie Green, Charles A. E. Baird

Feb 1, 2026

The Bone & Joint Journal

Sarcoma Diagnosis and Treatment

article

Clear cell sarcoma

James E. Archer, Scott Evans, Natalie Green, Charles A. E. Baird

February 1, 2026article en

Abstract

The Bone & Joint JournalVol. 108-B(2)

Royal Orthopaedic Hospital (GB)

Good health and well-being

Openalex Percentile: Top 72%

Sarcoma Diagnosis and Treatment

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clear cell sarcoma — James E. Archer, Scott Evans, et al. · The Bone & Joint Journal (2026) | TGRS Research Map | TGRS